Abstract:New 9-(alkyl/aryl)-4-fluoro-6-oxo [1,2,5]thiadiazolo [3,4-h]quinoline-5-carboxylic acids and their esters were designed and synthesized. A detailed discussion of the reactions utilized in the preparation of the intermediate and target compounds is reported. All the newly synthesized compounds were fully characterized using all the physico-chemical means needed. All the intermediates and the final esters and acids were tested against bacterial and fungal strains. The acids 25a and 25c proved to be very active a… Show more
“…The Schiff bases and thiazolidinones of 1‐cyclopropyl‐6‐fluoro‐7‐[4‐(2,3‐dichlorophenyl)piperazin‐1‐yl]‐4‐quinolones 17–19 showed moderate‐to‐weak activities against A. niger , A. clavatus , and C. albicans with MIC values ranging from 100 to >1000 μg/ml . The SAR indicated that the antifungal activity of 17 , 18, and 19 (Figure ) was at the same level, suggesting the introduction of a basic nitrogen heterocycle at the C‐7 position could not increase the activity.…”
More than 300 million people suffer from the incidence of life‐threatening invasive fungal infections, resulting in over 1.35 million deaths annually. Currently, the antifungal agents available in clinics are rather limited, and the rapid development of resistance to the existing antifungal drugs has further aggravated mortality. Quinolones possess a broad spectrum of chemotherapeutic properties and demonstrate considerable antifungal activities as well. Various quinolone derivatives have been screened for their antifungal activities, and some of them exhibit excellent potency against both drug‐susceptible and drug‐resistant fungi. This review aims to outline the recent advances in quinolone derivatives as potential antifungal agents and summarize the structure–activity relationship, to provide insights for the rational design of more active candidates.
“…The Schiff bases and thiazolidinones of 1‐cyclopropyl‐6‐fluoro‐7‐[4‐(2,3‐dichlorophenyl)piperazin‐1‐yl]‐4‐quinolones 17–19 showed moderate‐to‐weak activities against A. niger , A. clavatus , and C. albicans with MIC values ranging from 100 to >1000 μg/ml . The SAR indicated that the antifungal activity of 17 , 18, and 19 (Figure ) was at the same level, suggesting the introduction of a basic nitrogen heterocycle at the C‐7 position could not increase the activity.…”
More than 300 million people suffer from the incidence of life‐threatening invasive fungal infections, resulting in over 1.35 million deaths annually. Currently, the antifungal agents available in clinics are rather limited, and the rapid development of resistance to the existing antifungal drugs has further aggravated mortality. Quinolones possess a broad spectrum of chemotherapeutic properties and demonstrate considerable antifungal activities as well. Various quinolone derivatives have been screened for their antifungal activities, and some of them exhibit excellent potency against both drug‐susceptible and drug‐resistant fungi. This review aims to outline the recent advances in quinolone derivatives as potential antifungal agents and summarize the structure–activity relationship, to provide insights for the rational design of more active candidates.
“…Various derivatives prove to be very potent against bacterial and fungal strains and currently in clinical use [6,7]. In a program aimed to synthesize biologically active compounds, in detail we are searching for a hybridization of the fluroquinolone with benzimidazole [8][9][10][11]. Herein, the carboxylic acid moiety was coupled with o-phenylenediamine and thereafter cyclized to produce the target compound.…”
Cancer is one of the leading causes of death worldwide, and it has a major impact on public health. Phosphatidylinositol 3‐kinase (PI3Kα) has been recognized as a promising drug target for developing anticancer agents. Herein, a series of N‐phenyl‐6‐fluoro‐4‐hydroxy‐2‐quinolone‐3‐carboxamides was developed to target PI3Kα. All synthesized compounds were characterized using FT‐IR, NMR (1H and 13C) and elemental analysis. All synthesized chemical analogues exerted distinctive anticancer activity. They inhibited the growth of human epithelial colorectal adenocarcinoma (Caco‐2) with IC50 values between 48.63–378 μM, and human colon cancer (HCT‐116) cell lines with IC50 values between 44–664 μM. Computational modelling studies provided important biological insight. Induced‐fit docking (IFD) studies showed that the synthesized chemical analogues fit the kinase catalytic domains and form a significant H‐bond interaction network with key amino acids at the biding site. Furthermore, cheminformatics analyses indicated that all synthesized compounds were drug‐like permitting further animal testing or clinical development.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.